Stockscreener 앱 받기
12.97
4.00%
-0.54
전일 마감가:
$13.51
열려 있는:
$13.44
하루 거래량:
527.90K
Relative Volume:
0.48
시가총액:
$405.83M
수익:
-
순이익/손실:
$-69.47M
주가수익비율:
-2.3172
EPS:
-5.5973
순현금흐름:
$-73.92M
1주 성능:
-7.16%
1개월 성능:
-16.70%
6개월 성능:
-64.30%
1년 성능:
-47.79%
1일 변동 폭
$12.86
$13.54
1주일 범위
$12.76
$15.04
52주 변동 폭
$12.76
$50.40
Lenz Therapeutics Inc Stock (LENZ) Company Profile
명칭
Lenz Therapeutics Inc
전화
858-925-7000
주소
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
Compare LENZ vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
12.97 | 422.73M | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-14 | 재개 | Piper Sandler | Overweight |
| 2025-03-18 | 개시 | TD Cowen | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-12 | 개시 | H.C. Wainwright | Buy |
| 2024-04-15 | 개시 | Leerink Partners | Outperform |
| 2024-04-15 | 개시 | William Blair | Outperform |
| 2024-04-10 | 개시 | Citigroup | Buy |
| 2024-03-27 | 개시 | Piper Sandler | Overweight |
| 2023-02-23 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-02-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2023-01-25 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-01-06 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-04-14 | 개시 | BTIG Research | Buy |
| 2022-03-22 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | 개시 | Morgan Stanley | Overweight |
| 2021-07-20 | 개시 | SVB Leerink | Outperform |
모두보기
Lenz Therapeutics Inc 주식(LENZ)의 최신 뉴스
Fund Flows: What is the cash position of LENZ Therapeutics IncEarnings Recap Report & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Is LENZ Therapeutics Inc. benefiting from interest rate changesWeekly Trading Summary & Low Risk High Win Rate Picks - mfd.ru
Guidance Update: Can LENZ Therapeutics Inc be the next market leaderEarnings Overview Summary & Low Risk Entry Point Tips - baoquankhu1.vn
No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod - MSN
Investment Recap: Why is LENZ Therapeutics Inc stock going upQuarterly Profit Review & Growth Focused Entry Point Reports - baoquankhu1.vn
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO), LENZ Therapeutics (LENZ) and Amgen (AMGN) - The Globe and Mail
Aug Outlook: What are LENZ Therapeutics Incs recent SEC filings showingTrade Risk Summary & Technical Pattern Recognition Alerts - baoquankhu1.vn
Lenz Therapeutics price target lowered to $35 from $52 at BofA - TipRanks
LENZ Therapeutics stock price target lowered to $35 at BofA on slower ramp By Investing.com - Investing.com South Africa
LENZ Therapeutics stock price target lowered to $35 at BofA on slower ramp - Investing.com
Why Is LENZ Therapeutics Stock Trading Lower Today?LENZ Therapeutics (NASDAQ:LENZ) - Benzinga
What is the cash position of LENZ Therapeutics Inc.July 2025 Closing Moves & Fast Exit Strategy with Risk Control - mfd.ru
Is LENZ Therapeutics Inc. stock a buy or sell2025 Biggest Moves & Precise Buy Zone Tips - mfd.ru
Bull Run: Will LENZ Therapeutics Inc outperform its industry peersJuly 2025 Retail & High Win Rate Trade Tips - baoquankhu1.vn
LENZ Therapeutics and Sarah Jessica Parker Launch ‘Make it VIZZable’ Campaign - VisionMonday.com
In first celebrity partnership, Lenz Therapeutics taps Sarah Jessica Parker for vision campaign - Medical Marketing and Media
Insider Trends: Is Okeanis Eco Tankers Corp a defensive stockEarnings Growth Report & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Sovran Advisors LLC Has $4.98 Million Stock Holdings in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Aug PostEarnings: Why is LENZ Therapeutics Inc stock going up2025 Support & Resistance & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Nasdaq Moves: Why is LENZ Therapeutics Inc stock going upRate Hike & Daily Market Momentum Tracking - baoquankhu1.vn
Trading Action: Is LENZ Therapeutics Inc stock a buy or sellPortfolio Value Summary & Real-Time Volume Spike Alerts - baoquankhu1.vn
LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Unveiling a 155% Potential Upside in Biotechnology - DirectorsTalk Interviews
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc.LENZ - PR Newswire
Aug Spikes: What analysts say about LENZ Therapeutics Inc stockPortfolio Return Report & Risk Controlled Daily Plans - baoquankhu1.vn
We're Not Worried About LENZ Therapeutics' (NASDAQ:LENZ) Cash Burn - 富途资讯
Aug Shorts: Why is LENZ Therapeutics Inc stock going upProduct Launch & Weekly Stock Breakout Alerts - baoquankhu1.vn
LENZ Therapeutics and Sarah Jessica Parker announce the launch of Make it VIZZable, the VIZZ consumer campaign - marketscreener.com
LENZ Therapeutics (NASDAQ:LENZ) Trading Up 9.5%Should You Buy? - MarketBeat
Lenz Therapeutics, Sarah Jessica Parker launch ‘Make it VIZZable’ - TipRanks
LENZ Therapeutics Launches VIZZ Eye Drops for Near Vision Restoration Featuring Sarah Jessica Parker in "Make it VIZZable" Campaign - Quiver Quantitative
Lenz Therapeutics launch of "Make It Vizzable" with Sarah Jessica Parker as a brand ambassador - marketscreener.com
LENZ Therapeutics and Sarah Jessica Parker announce the launch of 'Make it VIZZable”, the VIZZ consumer campaign - The Manila Times
LENZ Therapeutics and Sarah Jessica Parker announce the launch of "Make it VIZZable", the VIZZ consumer campaign - PR Newswire
Sarah Jessica Parker Reveals the Health Issue That Almost Got in the Way of Her Favorite Pastime (Exclusive) - People.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ ... - Bluefield Daily Telegraph
Market Review: Will LENZ Therapeutics Inc stock continue upward momentumMarket Trend Review & Weekly Setup with ROI Potential - Bộ Nội Vụ
Shorts Report: How LENZ Therapeutics Inc stock reacts to global recession fearsTake Profit & Fast Exit Strategy with Risk Control - moha.gov.vn
A Look At LENZ Therapeutics (LENZ) Valuation After VIZZ Launch Momentum And New Lunatus Agreement - Yahoo Finance
Published on: 2026-01-12 22:19:01 - Улправда
Aug Momentum: Will LENZ Therapeutics Inc outperform its industry peers2025 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn
LENZ Therapeutics (LENZ) Is Down 7.1% After VIZZ Middle East Deal And Early Launch DataHas The Bull Case Changed? - Yahoo Finance
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
How sustainable is LENZ Therapeutics Inc. stock dividend payoutJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - Улправда
Will LENZ Therapeutics Inc. stock see insider buyingJuly 2025 Short Interest & Accurate Intraday Trading Signals - Улправда
FOMO Trade: Why LENZ Therapeutics Inc. stock is recommended by analysts2025 Trading Volume Trends & Technical Pattern Based Signals - moha.gov.vn
LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a Potential 245% Upside in the Biotechnology Sector - DirectorsTalk Interviews
LENZ Therapeutics Reports Preliminary Q4 2025 Results, Highlights VIZZ Launch - VisionMonday.com
Can LENZ Therapeutics Inc. stock reach $100 price targetJuly 2025 Patterns & Real-Time Buy Signal Alerts - ulpravda.ru
LENZ Therapeutics (NASDAQ:LENZ) Sets New 52-Week LowHere's Why - MarketBeat
Why LENZ Therapeutics Inc. stock is recommended by analystsTrade Risk Assessment & Community Verified Trade Alerts - ulpravda.ru
Lenz Therapeutics Inc (LENZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):